Session Abstract – PMWC 2019 Silicon Valley
The PMWC 2019 Data Applications in Clinical Diagnostics Showcase will take place on Monday January 21 and Wednesday January 23 and will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
Confirmed Presenting Companies:
The PMWC 2019 Data Applications in Clinical Diagnostics Showcase will take place on Monday January 21 and Wednesday January 23 and will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
Confirmed Presenting Companies:
- Accelerated Medical Diagnostics, Inc.
- Ambry Genetics
- American Biooptics
- Baebies
- Binx Health
- BioCeryx
- Blueprint Genetics Inc.
- CareDx
- CellMax Life
- Center for Genomic Interpretation
- DiaCarta
- DxTerity
- GeneCentric Therapeutics, Inc.
- Genomic Health
- Harvard Medical School
- Inflammatix
- Inova Diagnostics
- Invitae
- KIT Bio, Inc.
- Natera
- Novigenix
- Perkin Elmer
- PierianDx
- ProterixBio, Inc.
- SmartGene
- Stanford
- TopoMD
- Travera
- UCLA
- UCSF
Session Chair Profile
Ph.D., Executive Chairman, Invitae Corporation
Biography
Randy Scott is Executive Chairman of Invitae Corporation (NYSE: NVTA), a leading genetic information company. Dr. Scott is also co-founder and Chairman of the Board for Genome Medical, a nationwide tele-genetics medical practice serving patients, physicians and hospital systems. Dr. Scott served as CEO of Invitae from 2012-2017 and previously founded Genomic Health (NASDAQ: GHDX) in 2000 where he served as Chairman and CEO for nine years and Executive Chairman for three years. Prior to Genomic Health Dr. Scott was a cofounder, Chief Scientific Officer and President at Incyte (NASDAQ: INCY), a genomic information company. Dr. Scott, an author of more than 40 scientific publications, 20 patents, and recipient of numerous awards, holds a Bachelor of Science degree in Chemistry from Emporia State University and a Ph.D. in Biochemistry from the University of Kansas.
